Cold stimulus fingertip lacticemy test - An effective method to monitor acute therapeutic intervention on primary Raynaud's phenomenon and systemic sclerosis

Rheumatology

Volumn 47, Issue 1, 2008, Pages 80-83

  Fontenelle, S M A ^a   Kayser, C ^a   Pucinelli, M L C ^a   Andrade, Luis E C ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Calcium channel blockers; Lactate; Microcirculation; Raynaud's phenomenon; Systemic sclerosis

Indexed keywords

LACTIC ACID; NIFEDIPINE; PLACEBO;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COLD STRESS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; FEMALE; FINGER BLOOD FLOW; HEMODYNAMICS; HUMAN; LACTATE BLOOD LEVEL; MALE; MICROCIRCULATION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; RAYNAUD PHENOMENON; SINGLE DRUG DOSE; SYSTEMIC SCLEROSIS; TISSUE PERFUSION;

ADMINISTRATION, SUBLINGUAL; ADULT; COLD; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; DRUG MONITORING; FEMALE; FINGERS; HUMANS; LACTIC ACID; MALE; MICROCIRCULATION; MIDDLE AGED; NIFEDIPINE; RAYNAUD DISEASE; SCLERODERMA, DIFFUSE; SCLERODERMA, LOCALIZED; SCLERODERMA, SYSTEMIC; TREATMENT OUTCOME; VASODILATOR AGENTS;

EID: 37349077694     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kem300     Document Type: Article

References (17)

1. LeRoy EC, Medsger TA Jr. Raynaud's phenomenon: A proposal for classification. Clin Exp Rheumatol 1992; 10:485-8.
2. Maricq HR, McGregor AR, Diat F et al. Major clinical diagnoses found among patients with Raynaud phenomenon from the general population. J Rheumatol 1990; 17: 1171-6.
3. George CF. Nifedipine: A calcium channel blocking drug. BI J Clin Pract 1987;41:1059-61.
4. Creager MA, Pariser KM, Winston EM, Rasmussen HM, Miller KB, Coffman JD. Nifedipine-Induced fingertip vasodilation in patients with Raynaud's pheomenon. Am Heart J 1984;108:370-3.
5. Rodeheffer RJ, Rommer JA, Wigley F, Smith CR. Controlled double-blind trial of nifedipine in the treatment of Raynaud's phenomenon. N Engl J Med 1983;308:880-3.
6. Kallenberg CG, Wouda AA, Kuitert JJ, Tijssen J, Weaseling H. Nifedipine in Raynaud's phenomenon: Relationship between immediate short term and longterm effects. J Rheumatol 1987;14:284-90.
7. Thompson AE, Shea B, Welch V, Fenlon D, Pope JE. Caldum-channel blockers for Raynaud's phenomenon in systemic sclerosis. Arthritis Rheum 2001;44:1841-7.
8. Thompson AE, Pope JE. Calcium channel blockers for primary Raynaud's phenomenon: A meta-analysis. Rheumatology 2005;44:145-50,
9. Winston EL, Pariser KM, Miller KB, Salem DN, Creager MA. Nifedipine as a therapeutic modality for Raynauds phenomenon. Arthritis Rheum 1983;26:1177-80.
10. Grassi W, Core P, Carlino G, Cervini C. Acute effects of single dose nifedipine on cold-induced changes of microvascular dynamics in systemic sclenosis. Br J Rheumatol 1994;33:1154-61.
11. Wollersholm H, Thien T, van't Lear A. Nifedipine in primary Reynaud's phenomenon and in scleroderma: Oral versus sublingual hemodynamic effects. J Clin Pharmacol 1987;27:907-13.
12. Pucinelli MLC, Fontenelle SMA, Andrade LEC. Determination of fingertip lacticerny before and after cold stimulus in patients with primary Raynaud's phenomenon and systemic sclerosis. J Rheumatol 2002;29:1401-3.
13. Kayser C, Pucinelli ML, Fontenelle SM, Andrade LE. Cold stimulus-fingertip lacticemy: Standardization of the test in normal volunteers.and diagnostic application for systemic sclerosis. Microvasc Res 2005;70:84-9.
14. Masi AT, Rodnan GP, Medisger TA et al. Subcommittee for scleroderma criteria of the ARA diagnostic and therapeutic criteria committee: Preliminary criteria for the classification of systemic sclerosis. Arthritis Rheum 1980;23:581-90.
15. Harrick AL. Pathogenesis of Raynaud's phenomenon. Rheumatology 2005;44:587-96.
16. Burch GE, Herb JM, Sun CS. Fine structure of digital vascular lesions in Raynaud's phenomenon and disease. Angiology 1981;21:361-76.
17. Rodnan GP, Myerowltz RL, Justh GO. Morphologic changes in the digital arteries of patients with progressive systemic sclerosis (scleroderma) and Raynaud phenomenon. Medicine 1980;59:393-408.